Our TCR.strong metric comprised of 5 immunological genes (TNFRSF4, IRF8, STAT4, TNIP3, ICOS—the latter previously identified as a potential marker for T cell mediated response to anti-PD1 monotherapy in melanoma; Xiao et al., 2020). The gene discussed is TNFRSF4; the disease is melanoma.